Cim LLC Cuts Stake in Chemed Co. (NYSE:CHE)

Cim LLC cut its stake in Chemed Co. (NYSE:CHE) by 11.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,980 shares of the company’s stock after selling 244 shares during the quarter. Cim LLC’s holdings in Chemed were worth $1,136,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Rise Advisors LLC purchased a new position in shares of Chemed in the first quarter valued at approximately $26,000. GAMMA Investing LLC grew its holdings in shares of Chemed by 34.4% during the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock worth $47,000 after buying an additional 22 shares in the last quarter. Mather Group LLC. acquired a new stake in shares of Chemed in the first quarter valued at about $67,000. EntryPoint Capital LLC boosted its position in Chemed by 14.0% during the first quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock worth $94,000 after acquiring an additional 18 shares during the last quarter. Finally, Quarry LP grew its stake in Chemed by 721.7% during the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after acquiring an additional 166 shares in the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, EVP Nicholas Michael Westfall sold 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $561.58, for a total value of $1,123,160.00. Following the completion of the transaction, the executive vice president now owns 5,990 shares of the company’s stock, valued at $3,363,864.20. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, EVP Nicholas Michael Westfall sold 2,000 shares of Chemed stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $561.58, for a total value of $1,123,160.00. Following the completion of the transaction, the executive vice president now owns 5,990 shares in the company, valued at $3,363,864.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director George J. Walsh III sold 200 shares of Chemed stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $577.95, for a total transaction of $115,590.00. Following the completion of the transaction, the director now owns 3,446 shares of the company’s stock, valued at approximately $1,991,615.70. The disclosure for this sale can be found here. Over the last quarter, insiders sold 9,144 shares of company stock valued at $5,264,839. 3.32% of the stock is currently owned by company insiders.

Chemed Stock Down 1.4 %

NYSE CHE opened at $592.70 on Wednesday. Chemed Co. has a 52 week low of $497.36 and a 52 week high of $654.62. The business’s fifty day simple moving average is $575.72 and its 200-day simple moving average is $575.12. The firm has a market cap of $8.97 billion, a PE ratio of 31.90, a P/E/G ratio of 2.40 and a beta of 0.44.

Chemed (NYSE:CHE) last posted its earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). Chemed had a net margin of 12.88% and a return on equity of 29.21%. The business had revenue of $595.88 million during the quarter, compared to analysts’ expectations of $599.20 million. During the same quarter in the prior year, the firm earned $4.71 EPS. Chemed’s revenue for the quarter was up 7.6% compared to the same quarter last year. Research analysts expect that Chemed Co. will post 21.77 EPS for the current year.

Chemed Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Monday, August 12th were paid a $0.50 dividend. This is a positive change from Chemed’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend was Monday, August 12th. This represents a $2.00 annualized dividend and a dividend yield of 0.34%. Chemed’s dividend payout ratio (DPR) is presently 10.76%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.